A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia

REFERENCES

• Rozman C, Montserrat E. Chronic lymphocytic leukaemia. N Engl J Med 1995;333:1052–1057.
   Google Scholar
• Molica S. Prognostic factors in chronic lymphocytic leukae-mia. In: Cheson BD, editor. Chronic lymphocytic leukemias. 2nd ed. New York: Marcel Dekker; 2001. p 231–260.
   Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
   Google Scholar
• Binet JL, L,epoprier M, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977;40:855–864.
   Google Scholar
• Montserrat E, Vinolas N, Reverter JC, Rozman C. Natural history of chronic lymphocytic leukaemia: on the progression and prognosis of early clinical stages. Nouv Rev Fr Hematol 1988;30:359–361.
   Google Scholar
• French Cooperative Group on Chronic Lymphocytic Leuke-mia. Natural history of stage A chronic lymphocytic leukaemia untreated patients. Br J Haematol 1990;76:45–57.
   Google Scholar
• Keating M, Lerner S, Kantarjian H, Freireich E, O'Brien S. The serum )32-microglobulin level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia (CLL). Blood 1995;86:606a.
   Google Scholar
• Hallek M, Langenmayer I, Nerl C, Knauf W, Dietzfelbinger H, Adorf D, Ostwald M, Busch R, Kuhn-Hallek I, Thiel E, Emmerich B. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, non-smoldering chronic lymphocytic leukemia. Blood 1999;93: 1732–1737.
   Google Scholar
• Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D. Prognostic importance of serum soluble CD23 level in chronic lympho-cytic leukemia. Blood 1996;88: 4259–4264.
   Google Scholar
• Molica S, Levato D, Cascavilla N, Levato L, Musto P. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and )32-microglobulin in B-cell chronic lymphocytic leukemia. Eur J Haematol 1999;62: 117–122.
   Google Scholar
• Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848–1854.
   Google Scholar
• Damle RN, Wasil T, Fais F, Ghiotti F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz Jet al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94: 1840–1847.
   Google Scholar
• Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immu-noglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348: 1764–1775.
   Google Scholar
• Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, Dohner H, Stilgenbauer S. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410–1416.
   Google Scholar
• Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910–1916.
   Google Scholar
• Shanafelt TD, Geyer SM, Kay NE. Prognosis at diagnosis: integrating molecular biology insights into clinical practice for patients with CLL. Blood 2004;103:1202–1210.
   Google Scholar
• Molica S. Progression and survival studies in early chronic lymphocytic leukemia. Blood 1991;78:895–899.
   Google Scholar
• Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R, Leporrier M, Jaubert J, Lepeu G, Dreyfus B et al. Cholorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leuke-mia. N Engl J Med 1998;338:1506–1514.
   Google Scholar
• Catovsky D, Halsey J, Richards S et al. Sex as a prognostic factor in CLL. An analysis from MRC trials. IX IWCLL, San Diego 22–24 March 2002:32a.
   Google Scholar
• Dighiero G. Is chronic lymphocytic leukemia one disease? Haematologica 2002;87 (Suppl. II):31–33.
   Google Scholar
• CLL Trialists' Collaborative Group. Chemotherapeutic op-tions in chronic lymphocytic leukemia: a meta-analysis of randomized trials. J Natl Cancer Inst 1999;91:861–868.
   Google Scholar
• Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE, Corcoran MM, Chapman RM, Thomas PW, Copplestone JA et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002;100:1177–1184.
   Google Scholar
• Guarini A, Gaidano G, Mauro FR, Capello D, Mancini F, De Propis MS, Mansini M, Gentile M, Breccia M, Cuneo A et al. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 2003;102:1035–1041.
   Google Scholar
• Magnac C, Porcher R, Davi F, Nataf J, Payelle-Brogard B, Tang RP, Oppezzo P, Levy V, Dighiero G, Ajchenbaum-Cymbalista F. Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL. Leukemia 2003;17:133–137.
   Google Scholar
• Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM, Albitar M. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001;98: 181–186.
   Google Scholar
• Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101:4944–4951.
   Google Scholar
• Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG. CD38 expression and immuno-globulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expres-sion may vary during the course of the disease. Blood 2002;99: 1023–1029.
   Google Scholar
• Vasconcelos Y, Davi F, Levy V, Oppezzo P, Magnac C, Michel A, Yamamoto M, Pritsch 0, Merle-Beral H, Maloum K et al. Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lympho-cytic leukemia. J Chin Oncol 2003;21:3928–3932.
   Google Scholar
• Catovsky D, Matutes E, Morilla A, Burford A, Brito-Babapulle V, Del Giudice I, Orchard J, Oscier DG, Halsey J, Richards S. Gender as a prognostic factor in CLL. Biological pointers to the improved outcome of women. Blood 2004;104 (Suppl. 1):274a.
   Google Scholar
• Hamblin TJ, Orchard JA, Davies ZA, Ibbotson RE, Gardiner AC, Copplestone A, Oscier DG. In chronic lymphocy-tic leukemia females survive for longer than males even in patients with unmutated immunoglobulin genes. Blood 2004;104 (Suppl. 1):9a.
   Google Scholar
• Multiple Myeloma 9th International Workshop, May 23–27, 2003, Salamanca, Spain. Hematol J 2003;4 (Suppl. 1):S282.
   Google Scholar